These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12608549)

  • 1. Insulin resistance highly associates with hypertension in IgA nephropathy.
    Eiro M; Katoh T; Sakuma Y; Sakurai K; Suzuki H; Asahi K; Watanabe K; Watanabe T
    Clin Nephrol; 2003 Feb; 59(2):71-8. PubMed ID: 12608549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of sensitive screening for abnormal glucose metabolism in patients with IgA nephropathy.
    Jia X; Pan X; Xie J; Shen P; Wang Z; Li Y; Wang W; Chen N
    Clin Nephrol; 2016 Jan; 85(1):30-7. PubMed ID: 26636325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.
    Rauta V; Finne P; Fagerudd J; Rosenlöf K; Törnroth T; Grönhagen-Riska C
    Clin Nephrol; 2002 Aug; 58(2):85-94. PubMed ID: 12227693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
    Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):947-955. PubMed ID: 27026518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher HOMA-IR index and correlated factors of insulin resistance in patients with IgA nephropathy.
    Yang Y; Wei RB; Wang YD; Zhang XG; Rong N; Tang L; Chen XM
    Clin Nephrol; 2012 Nov; 78(5):353-8. PubMed ID: 22579275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors].
    Shi X; Chen X; Liu S; Zhuang Y; Zhang Y
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):399-403. PubMed ID: 12137603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indian scenario of IgA nephropathy: a systematic review and meta-analysis.
    Khairwa A
    Afr Health Sci; 2021 Mar; 21(1):159-165. PubMed ID: 34394293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
    Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V
    Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.
    Myllymäki J; Honkanen T; Syrjänen J; Helin H; Rantala I; Pasternack A; Mustonen J
    Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
    J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of vascular lesions in IgA nephropathy and their influencing factors, a study of 1,005 cases].
    Wu J; Chen XM; Shi SZ
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(4):289-93. PubMed ID: 12812644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular diseases and their risk factors in IgA nephropathy.
    Myllymäki J; Syrjänen J; Helin H; Pasternack A; Kattainen A; Mustonen J
    Nephrol Dial Transplant; 2006 Jul; 21(7):1876-82. PubMed ID: 16522659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and natural history of IgA nephropathy.
    Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
    Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal dopamine and salt sensitivity of blood pressure in IgA nephropathy.
    Pestana M; Santos J; Santos A; Coroas A; Correia F; Serrão P; Valbuena C; Soares-da-Silva P
    Kidney Blood Press Res; 2004; 27(2):78-87. PubMed ID: 14718752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
    Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
    Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy.
    Syrjänen J; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 2000 Jan; 15(1):34-42. PubMed ID: 10607765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The product of duration and amount of proteinuria (proteinuria index) is a possible marker for glomerular and tubulointerstitial damage in IgA nephropathy.
    Eiro M; Katoh T; Kuriki M; Asano K; Watanabe K; Watanabe T
    Nephron; 2002 Apr; 90(4):432-41. PubMed ID: 11961402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal vascular lesions and the occurrence of hypertension in patients with IgA nephropathy].
    Boulahrouz R; Stanescu C; Charasse C; Ang KS; Le Cacheux P; Leonetti F; Rioux N; Ramee MP; Simon P
    Arch Mal Coeur Vaiss; 2004; 97(7-8):782-5. PubMed ID: 15506066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy.
    Donadio JV; Bergstralh EJ; Grande JP; Rademcher DM
    Nephrol Dial Transplant; 2002 Jul; 17(7):1197-203. PubMed ID: 12105241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.